RIGGS RORY B

Related Filers (6)

Other (2)

144
Tuesday, 1/2/2024
Filing for proposed sale of securities under Rule 144
144
Monday, 5/22/2023
Filing for proposed sale of securities under Rule 144
Show More

Ownership (109)

4
Thursday, 1/4/2024
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/3/2024
Cibus, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/3/2024
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/14/2023
Cibus, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/14/2023
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Monday, 10/2/2023
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/8/2023
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/27/2023
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/26/2023
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4/A
Thursday, 6/15/2023
Cibus, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 6/12/2023
Cibus, Inc.: Major Shareholders
3
Friday, 6/2/2023
Cibus, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/2/2023
Cibus, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/22/2023
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Friday, 5/12/2023
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/4/2023
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/30/2023
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Friday, 2/17/2023
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/3/2023
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/13/2022
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Monday, 11/21/2022
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/4/2022
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/15/2022
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Thursday, 8/11/2022
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/5/2022
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/29/2022
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Monday, 6/13/2022
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/23/2022
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Monday, 4/4/2022
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/30/2022
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Monday, 3/21/2022
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Friday, 3/18/2022
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/30/2021
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Thursday, 11/18/2021
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Monday, 10/4/2021
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/30/2021
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Friday, 7/2/2021
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/29/2021
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/22/2021
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/8/2021
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Friday, 6/4/2021
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/28/2021
FIBROGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/11/2021
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Friday, 4/2/2021
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 2/26/2021
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/5/2021
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 10/23/2020
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Thursday, 10/22/2020
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
4
Friday, 10/2/2020
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/2/2020
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/26/2020
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/23/2020
Royalty Pharma plc: Statement of changes in beneficial ownership of securities
3
Monday, 6/15/2020
Royalty Pharma plc: Initial statement of beneficial ownership of securities
4
Monday, 6/8/2020
FIBROGEN INC: Statement of changes in beneficial ownership of securities
4
Thursday, 5/28/2020
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/2/2020
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/3/2020
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/2/2019
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/2/2019
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/26/2019
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/7/2019
FIBROGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/2/2019
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/3/2019
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/2/2018
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/28/2018
FIBROGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/3/2018
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/20/2018
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/7/2018
FIBROGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/3/2018
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/14/2018
FIBROGEN INC: Statement of changes in beneficial ownership of securities
4
Friday, 3/9/2018
FIBROGEN INC: Statement of changes in beneficial ownership of securities
5
Wednesday, 2/14/2018
FIBROGEN INC: Annual statement of changes in beneficial ownership of securities
4/A
Wednesday, 1/3/2018
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/3/2018
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2017
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/15/2017
FIBROGEN INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2017
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/29/2017
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/9/2017
FIBROGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/4/2017
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/3/2017
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/16/2016
FIBROGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/4/2016
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/5/2016
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2016
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2016
FIBROGEN INC: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 4/20/2016
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/4/2016
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/5/2016
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/2/2015
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/15/2015
FIBROGEN INC: Statement of changes in beneficial ownership of securities
4
Thursday, 7/2/2015
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/22/2015
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/5/2015
FIBROGEN INC: Statement of changes in beneficial ownership of securities
4
Thursday, 4/2/2015
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/5/2015
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/21/2014
FIBROGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 11/17/2014
FIBROGEN INC: Statement of changes in beneficial ownership of securities
Show More